Elavil and Invanz drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Elavil (amitriptyline hydrochloride) and Invanz (ertapenem sodium). Common drug interactions include gastric ulcer among females and fall among males.

The phase IV clinical study analyzes what interactions people have when they take Elavil and Invanz. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Elavil?

Elavil has active ingredients of amitriptyline hydrochloride. It is often used in depression. eHealthMe is studying from 20,724 Elavil users. Check the latest studies of Elavil.

What is Invanz?

Invanz has active ingredients of ertapenem sodium. It is often used in urinary tract infection. eHealthMe is studying from 3,961 Invanz users. Check the latest studies of Invanz.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 14, 2026

20 people who take Elavil and Invanz together, and have interactions are studied.

What are the common drug interactions of Elavil and Invanz, by gender? *:

female:

Gastric ulcer (stomach ulcer)
Malaise (a feeling of general discomfort or uneasiness)
Pain
Vomiting
Ascites (accumulation of fluid in the abdominal cavity)
Syncope (loss of consciousness with an inability to maintain postural tone)
Chest discomfort
Chills (felling of cold)
Device occlusion
Fatigue (feeling of tiredness)

male:

Fall
Asthenia (weakness)

What are the common drug interactions of Elavil and Invanz, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Abasia (inability to walk)
Asthenia (weakness)
Dysarthria (speech disorder)

30-39:

n/a

40-49:

Hypotension (abnormally low blood pressure)
Pleural effusion (water on the lungs)
Acute respiratory failure
Cellulitis (infection under the skin)
Dizziness
Dyspnoea (difficult or laboured respiration)
Fluid overload (too much fluid in the blood)
Gastric ulcer (stomach ulcer)
Malaise (a feeling of general discomfort or uneasiness)
Pain

50-59:

Chronic kidney disease
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Nephrogenic anaemia (anaemia due to kidney disease)
Renal failure (kidney dysfunction)
Renal injury (kidney injury)

60+:

Fall
Tooth discolouration (a change in colour of teeth)
Escherichia bacteraemia (presence of bacteria escherichia coli in the blood)
Sepsis (a severe blood infection that can lead to organ failure and death)
Asthenia (weakness)

What are the existing conditions these people have? *

Pulmonary Hypertension (increase in blood pressure in the lung artery): 9 people, 45.00%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 5 people, 25.00%
Oedema (fluid collection in tissue): 5 people, 25.00%
Constipation: 4 people, 20.00%
Itching: 3 people, 15.00%
Pain: 3 people, 15.00%
Osteomyelitis (infection of bone): 3 people, 15.00%
Arteriosclerosis Coronary Artery (thickening and hardening of arteries- coronary artery): 2 people, 10.00%
Sepsis (a severe blood infection that can lead to organ failure and death): 2 people, 10.00%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Elavil and Invanz?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously